As a result, this study aimed to investigate whether APOE4 influences changes in brain structure within regions implicated in cognition in PD, specifically gray matter alterations measured by GMV and CTh, using data from the Parkinson’s Progression Markers Initiative (PPMI). The gene discussed is APOE; the disease is Parkinson disease.